Le Lézard
Classified in: Health
Subjects: SCZ, DEI

Ten Windsor Care Centers Achieve 4 & 5-Star CMS Ratings


Ten Windsor Care Center across California and Arizona achieve overall 4 and 5-Star ratings by the Centers for Medicare and Medicaid Services.

LOS ANGELES, July 12, 2022 /PRNewswire-PRWeb/ -- Windsor care centers, providers of rehabilitation and short- and long-term healthcare across California and Arizona, announced that ten of their skilled nursing facilities have been awarded a 4 or 5-Star overall rating by the Centers for Medicare and Medicaid Services (CMS).

CMS created the Five-Star Quality Rating System to help consumers, their families, and caregivers compare nursing homes and navigate the intricacies of choosing the appropriate facility for their family member. Nursing homes are assigned an overall star rating between one and five stars by CMS and specific ratings in each of the following three areas:

1. Health inspections (state conducted inspections of food preparation, infection control, medication management, residents' rights and quality of life, and proper skin care);
2. Nurse staffing (average number of nursing care minutes patients receive daily); and
3. Medical quality measures (self-reported and claims-based medical data for the latest four calendar quarters).

"Everyone at Windsor Elk Grove Care and Rehabilitation Center is excited to again achieve a 5-Star rating," says Karl Ambler, facility Administrator. "It takes daily execution and superb routine of each team member, and they are all up to the challenge. This achievement is a testament to the professionalism and dedication of our 5-Star staff."

Three Windsor locations achieved a 5-star rating:
1.    Fremont
2.    Elk Grove
3.    Hayward

Seven locations achieved a 4-star rating:
1.    Concord
2.    Country Drive
3.    Hayward P.A.
4.    Maryland Gardens (AZ)
5.    Ridgecrest (AZ)
6.    San Diego
7.    Skyline

Media Contact

Ari Rosenstein, Windsor Healthcare, 3107344222, [email protected]

Twitter

 

SOURCE Windsor Healthcare


These press releases may also interest you

at 16:05
Nutcracker Therapeutics, Inc., a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology platform, today detailed data presented by its partners at the University of California, San Francisco...

at 16:05
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today...

at 16:05
Omeros Corporation , a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting immunologic disorders including...

at 16:05
VBI Vaccines Inc. (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided a business update and announced financial results for the quarter ended March 31, 2024. "To...

at 16:02
K-Bro Linen Inc. (the "Corporation") announced today a dividend of 10.00 cents CDN per common share of the Corporation for the period from May 1 to 31, 2024, to be paid on June 14, 2024 to holders of record of common shares on May 31, 2024. The...

at 16:01
Kodiak Sciences Inc. , today reported business highlights and financial results for the quarter ended March 31, 2024. "We continue to make excellent operational progress with our three clinical programs of tarcocimab, KSI-501 and KSI-101, as well as...



News published on and distributed by: